Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
Copyright 2024 – Finance News Network
Source: Finance News Network
16 Mar 2022 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discuses the company's recent sales win and its distribution agreement with distributor Thermo Fisher Scientific.
Read More10 Oct 2023 - Alex Hanly - CEO - Lithium Universe (ASX:LU7) objective is to construct a Lithium Project in Québec with utmost speed, and to assist Canada facilitate the transition towards cleaner energy.
Read More27 Apr 2022 - Acorn Capital Investment Fund (ASX:ACQ) Portfolio Manager Rick Squire discusses key factors behind commodity demand and which commodities to keep an eye on.
Read More15 Jul 2024 - Allan Mason, the former accountant to Kerry Packer during the height of his notoriety, speaks about his best-selling book and tips for cutting back tax costs.
Read More23 Apr 2021 - Theta Gold Mines Limited (ASX:TGM, OTCQB:TGMGF) CEO for Africa, Mitford Mundell, talks about the company's projects and its plans to bring open-pit mining to historical underground mines and exploit old workings.
Read More16 Aug 2023 - Tom Spurling - Executive Director - Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Read More10 Nov 2023 - A recent interview between Wexted Advisors and Finance News Network, sparked an impromptu conversation between former Wallabies Captain Simon Poidevin and Head of Sequoia Direct Paul Sanger, discussing the controversial current climate of the Rugby World Cup.
Read More10 Jun 2021 - Calima Energy Limited (ASX:CE1) Executive Chairman Glenn Whiddon provides an update on production at the company's projects in British Columbia and its plans for an active, low-risk drilling program developing proven reserves.
Read More12 Nov 2024 - Dr Chris Burns, the CEO of NOVONIX Limited (ASX:NVX), shares details on a significant supply agreement with Stellantis for synthetic graphite, a milestone for the North American battery market.
Read More03 Jun 2024 - Chris Gosselin interviews Dan Nicolaides on how Digital Asset Funds Management uses crypto market volatility for stable returns and risk management.
Read More
